1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with hydrazine in 19 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (hydrazine) | Trials (hydrazine) | Recent Studies (post-2010) (hydrazine) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 12,034 | 330 | 3,193 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (57.89) | 18.7374 |
1990's | 6 (31.58) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstrong, ML; Densen, P; Heistad, DD; Lopez, JA; Mügge, A; Padgett, RC; Piegors, DJ | 1 |
Felsen, D; Loo, MH; Marion, DN; Vaughan, ED | 1 |
McCall, CE; Salzer, WL | 1 |
Armstead, WM; Busija, DW; Leffler, CW; Mirro, R | 1 |
Bradley, LM; Czaja, JF; Goldstein, RE; Stambouly, JJ | 1 |
Ikeda, K; Sasaki, H; Sasaki, T; Shimura, S; Takishima, T | 1 |
Kadowitz, PJ; Underwood, DC | 1 |
Bradley, LM; Feuerstein, G; Goldstein, RE | 1 |
Blair, IA; Cragoe, EJ; Frazer, M; Limbird, LE; Reed, PW; Schwartzberg, MS; Sweatt, JD | 1 |
Daniel, EE; Serio, R | 1 |
Bradley, LM; Czaja, JF; Feuerstein, G; Goldstein, RE | 1 |
Darius, H; Lefer, AM; Smith, JB | 1 |
Myers, AK; Nakanishi, T; Ramwell, P | 1 |
Chignard, M; Selak, MA; Smith, JB | 1 |
Conger, JD; Falk, SA; Lanese, DM | 1 |
Hidaka, T; Ishizuka, T; Kawakami, M; Matsuki, Y; Nakamura, H; Suzuki, K | 1 |
Brasch, F; Falk, S; Göggel, R; Heydasch, U; Müller, KM; Uhlig, S; Wendel, A | 1 |
Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R | 1 |
Baumgartner, W; Kuebler, WM; Reppien, E; Samapati, R; Solymosi, EA; Uhlig, S; Yang, Y; Yin, J | 1 |
19 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and hydrazine
Article | Year |
---|---|
Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo.
Topics: Animals; Arteries; Arteriosclerosis; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Complement C5a; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Leukocytes; Lipids; Macaca fascicularis; Male; Platelet Activating Factor; Prostaglandins; Thromboxane A2; Triazoles; Vasoconstriction | 1992 |
Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
Topics: Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Fatty Acids, Unsaturated; Female; Hydrazines; Platelet Activating Factor; Pressure; Prostaglandin Endoperoxides, Synthetic; Quinolinium Compounds; Receptors, Prostaglandin; Receptors, Thromboxane; Renal Circulation; Thromboxane A2; Ureter; Ureteral Obstruction; Vascular Resistance; Vasoconstriction | 1990 |
Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.
Topics: Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Capillary Permeability; Drug Synergism; Endotoxins; Fatty Acids, Unsaturated; Hydrazines; Imidazoles; In Vitro Techniques; Indomethacin; Lipopolysaccharides; Lung; Perfusion; Platelet Activating Factor; Pulmonary Edema; Rabbits; Thromboxanes; Tumor Necrosis Factor-alpha | 1990 |
Permissive role of prostanoids in acetylcholine-induced cerebral vasoconstriction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cerebrovascular Circulation; Dinoprost; Fatty Acids, Unsaturated; Female; Hydrazines; Male; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Swine; Vasoconstriction | 1989 |
Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Female; Hemodynamics; Hydrazines; Hypoxia; Lung; Male; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Swine; Thromboxane A2; Vasoconstriction | 1989 |
Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cats; Fatty Acids, Unsaturated; Glucosamine; Glycoconjugates; Hydrazines; In Vitro Techniques; Indomethacin; Kinetics; Methysergide; Mucous Membrane; Phospholipid Ethers; Platelet Activating Factor; Radioisotope Dilution Technique; Thromboxane A2; Trachea; Tritium | 1989 |
Analysis of bronchoconstrictor responses to platelet-activating factor in the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Bronchi; Cats; Fatty Acids, Unsaturated; Female; Hydrazines; Lung Compliance; Male; Meclofenamic Acid; Phospholipid Ethers; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2 | 1989 |
The role of lipid mediators in hypoxic pulmonary vasoconstriction in newborns.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetophenones; Animals; Animals, Newborn; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Hydrazines; Hypoxia; Lipids; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; SRS-A; Swine; Tetrazoles; Thromboxane A2; Vasoconstriction | 1989 |
Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF.
Topics: Amiloride; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Humans; Hydrazines; Indomethacin; Platelet Activating Factor; Platelet Aggregation; Protons; Serotonin; Sodium; Thromboxane A2; Thromboxane B2 | 1987 |
Thromboxane effects on canine trachealis neuromuscular function.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Fatty Acids, Unsaturated; Female; Hydrazines; In Vitro Techniques; Leukotriene B4; Male; Muscle, Smooth; Neuromuscular Junction; Platelet Activating Factor; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Prostaglandins D; SRS-A; Thromboxane A2; Trachea | 1988 |
Circulatory effects of PAF-acether in newborn piglets.
Topics: 6-Ketoprostaglandin F1 alpha; Acetophenones; Animals; Animals, Newborn; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Indomethacin; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Wedge Pressure; Swine; Tetrazoles; Thromboxane B2; Vascular Resistance | 1989 |
Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydrazines; Lysosomes; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prostaglandin-Endoperoxide Synthases; Rabbits; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane B2; Thromboxane-A Synthase | 1985 |
Antagonism of PAF-induced death in mice.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Arachidonic Acids; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Diterpenes; Epinephrine; Fatty Acids, Unsaturated; Furans; Ginkgolides; Hydrazines; Lactones; Male; Mice; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridines; Thiazoles; Thromboxane A2 | 1988 |
Direct evidence for the existence of a neutrophil-derived platelet activator (neutrophilin).
Topics: Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Humans; Hydrazines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenylmethylsulfonyl Fluoride; Platelet Activating Factor; Platelet Aggregation | 1986 |
Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles.
Topics: Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Endothelin Receptor Antagonists; Endothelins; Fatty Acids, Unsaturated; Furans; Hydrazines; Kidney; Peptides, Cyclic; Platelet Activating Factor; Prostaglandins H; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Cyclic AMP; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hydrazines; Intercellular Adhesion Molecule-1; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Protein Kinase Inhibitors; Protein Kinases; Radioligand Assay; Receptors, Thromboxane; Thromboxane A2; Tumor Necrosis Factor-alpha | 1996 |
Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation.
Topics: Airway Resistance; Animals; Aspirin; Benzoquinones; Bridged Bicyclo Compounds, Heterocyclic; Capillary Permeability; Chloroquine; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Female; Hydrazines; In Vitro Techniques; Interleukin-6; Lipoxygenase Inhibitors; Lung; Male; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Pulmonary Circulation; Pulmonary Edema; Quinidine; Quinine; Quinolines; Rats; Rats, Wistar; Receptors, Thromboxane; Tumor Necrosis Factor-alpha; Vascular Resistance; Vasoconstriction | 1999 |
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 2002 |
Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase.
Topics: Animals; Capillary Permeability; Caveolin 1; Dexamethasone; Hydrazines; Lung; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Platelet Activating Factor; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase; Steroids | 2010 |